Artal Group S.A.

CIK 0001053906 · LUXEMBOURG, N4 · Quarter end: 2026-06-30 · Filed on: 2026-08-13 · Open the SEC source

Artal Group S.A. reported 2 positions worth $931.1M as of June 30, 2026 (13F filed August 13, 2026). Largest holding: CAVA (54.9%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$931.1M
2026 Q2
Positions
2
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
2026 Q2
2 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1CAVACava Group IncSH$510.7M54.85%6,507,990
2LXRXLexicon Pharmaceuticals IncSH$420.4M45.15%175,156,062

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Artal Group S.A. hold as of Q2 2026?

Artal Group S.A. reported 2 positions worth $931.1M in its Q2 2026 13F filing. Largest positions: CAVA (54.9%) and LXRX (45.1%).

What did Artal Group S.A. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Artal Group S.A. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.